|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01458938 |
|
Date of registration:
|
24/10/2011 |
|
Primary sponsor: |
|
|
Public title:
|
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
Substance P |
|
Scientific title:
|
Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study |
|
Date of first enrolment:
|
July 2009 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01458938 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Vinay Deshmukh, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Carolina Neurosurgery & Spine Associates |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Undergoing spinal surgery for medically refractory spinal radiculopathy,
- myelopathy or neurogenic claudication based on either history, physical examination
or radiologic studies demonstrating neural compression or degenerative disc disease.
- Undergoing surgery for medically refractory axial spinal pain.
Exclusion Criteria:
- Previous spinal procedures or operations,
- radicular pain,
- history of fibromyalgia,
- chronic pain,
- rheumatoid arthritis,
- autoimmune disorders,
- HIV,
- PTSD,
- Major Depressive Disorder,
- migraine headaches or active rhinosinusitis,
- nicotine intake
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Myelopathy
|
|
Neurogenic Claudication
|
|
Spinal Disease,
|
|
Spinal Radiculopathy,
|
|
Intervention(s)
|
|
Other: treatment plan
|
|
Secondary ID(s)
|
|
Substance P
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|